Results
The transcriptome of human fRPE cells.
We studied 23 primary human fRPE lines (Table S3) , all generated by the same method in a single laboratory 22 and cultured for at least 10 weeks under conditions that promote a differentiated phenotype 23 .
DNA from each line was genotyped at 2,372,784 variants. Additional variants were imputed and phased using Beagle v4.1 24 against 1000 Genomes Phase 3 25 for a total of ~13 million variants after filtering and quality control (see Methods).
Our goal was to identify RPE eQTL relevant to the tissue's role in both developmental and chronic eye diseases. The balance between glycolytic and oxidative cellular energy metabolism changes during development and differentiation 26 , and loss of RPE mitochondrial oxidative phosphorylation capacity may contribute to the pathogenesis of AMD 27 . We therefore obtained transcriptional profiles of each fRPE line cultured in medium that favors glycolysis (glucose plus glutamine) and in medium that promotes oxidative phosphorylation (galactose plus glutamine) 28 . We performed 75-base paired-end sequencing to a median depth of 52.7 million reads (interquartile range: 45.5 to 60.1 million reads) using a paired sample design to minimize batch effects. To determine the relationship between primary fRPE and other tissues, we visualized fRPE against 53 tissues from the GTEx Project v7 18 . The fRPE samples formed a distinct cluster situated between heart and skeletal muscle and brain (Fig. 1A) , tissues that, like the RPE, are metabolically active and capable of robust oxidative phosphorylation.
To identify genes with disproportionately high levels of expression in the fRPE, we compared the median RPKMs of fRPE genes against GTEx tissues. We defined fRPE-selective genes as those with median expression at least four standard deviations above the mean (see Methods). Under this definition, we found 100 protein-coding genes and 30 long non-coding RNAs (lncRNAs) to be fRPE-selective (Fig. 1B and Table   S5 ). Multiple previously defined RPE 'signature' genes [29] [30] [31] are present in our list including RPE65 (Fig. 1C) and RGR (Fig. 1D ). Using this set of genes, we performed Gene Set Enrichment Analysis (GSEA) 32 against 5,917 gene ontology (GO) annotations 33 . The two gene sets most enriched with fRPE-selective genes were pigment granule and sensory perception of light stimulus (FDR < 1x10 -3 ), consistent with the capacity of fRPE to produce melanin and the tissue's essential role in the visual cycle. Other highly enriched pathways relate to protein synthesis and secretion, eye morphogenesis, and cellular metabolism including oxidative phosphorylation. Table S6 lists the 29 GO pathways enriched using a conservative FWER < 0.05.
Transcriptomic differences across two metabolic conditions
To gain insight into the response of fRPE cells to altered energy metabolism, we compared gene expression between the two culture conditions using DESeq2 34 , correcting for age, sex, ancestry, RIN and batch (see Methods). A total of 837 genes showed evidence of significant differential expression (FDR < 1x10 -3 , Fig. 2A and Table S7 ). Notably, three of the top five differentially expressed genes are involved in lipid metabolism (SCD, INSIG1, and HMGCS2 in order). SCD codes for a key enzyme in fatty acid metabolism 35 , and its expression in RPE is regulated by retinoic acid 36 . INSIG1 encodes an insulin-induced protein that regulates cellular cholesterol concentration 37 . HMGCS2 encodes a mitochondrial enzyme that catalyzes the first step of ketogenesis 38 , and this enzyme plays a key role in phagocytosis-dependent ketogenesis in fRPE 39 .
To understand the broader impact induced by changes in energy metabolism, we performed pathway enrichment analysis using GSEA 32 and found that the top two upregulated pathways in galactose medium are cholesterol homeostasis and mTORC1 signaling (FDR < 1x10 -4 , Fig. 2B ). Consistent with the cholesterol finding, forcing cells to rely primarily on oxidation of glutamine for ATP generation increases expression of a suite of genes that promotes lipid synthesis and import (Fig. 2C) .
fRPE-selective genes are enriched in genetic ocular diseases Disease-associated genes can have elevated expression levels in effector tissues 40 . To determine whether ocular disease genes have elevated expression levels in fRPE, we used a manually curated list of 257 ocular disease related genes 41 that includes genes for inherited retinal disorders (n = 238), glaucoma (n = 8) and other risk genes (n = 11, Table S2 ). Compared to all other protein-coding genes, ocular disease-related genes are expressed at higher levels in fRPE (two-sided t-test p-value: 1.6x10 -10 ). Further, ocular disease gene expression demonstrated a larger elevation in fRPE than GTEx tissues (Fig. 3A) , suggesting fRPE as a model system for a number of eye diseases. As a control, we repeated the analysis for epilepsy genes (n = 189) and observed elevated expression levels in brain tissues as we expected (Fig. S16 ).
Unlike Mendelian ocular diseases, polygenic ocular disorders are characterized by variants with smaller effect sizes scattered throughout the genome. To determine the heritability explained by fRPE, we performed stratified linkage disequilibrium (LD) score regression using two well-powered GWAS on AMD 42 and myopia 43 .
Using a previously established pipeline 44 , we selected the top 500 tissue-enriched genes and assigned 6 variants within one kilobase of these genes to each tissue (see Methods). Risk variants for both complex diseases were better enriched around fRPE-selective genes than GTEx tissue-selective genes ( Fig. 3B and C) .
As an assessment of the robustness of the LD score regression results, we repeated the analysis with the top 200 and 1000 tissue-specific genes. A high ranking for fRPE was consistent across all three cutoffs (Fig. S17 ).
Expression and splicing quantitative trait loci discovery
To determine the genetic effects on gene expression in fRPE, we used RASQUAL 45 to map eQTL by leveraging both gene-level and allele-specific count information to boost discovery power. Multiple-hypothesis testing for both glucose and galactose conditions was conducted jointly with a hierarchical procedure called TreeQTL 46 . At FDR < 0.05, we found 726 shared, 272 glucose-specific, and 191 galactose-specific eQTL (Table 1 , S10 and S11, Fig. 4A and Fig. S12-13 ). An example of a glucose-specific eQTL is ABCA1 (Fig. 4B ), which encodes an ATP-binding cassette transporter that regulates cellular cholesterol efflux 47 . Common variants near ABCA1 have been associated with glaucoma 48 and AMD 42 . An example of a galactose-specific eQTL is PRPF8 (Fig. 4C ), which encodes a splicing factor 49 . PRPF8 mutations are a cause of retinitis pigmentosa 50 and lead to RPE dysfunction in a mouse model 51 . An example of a shared eQTL is RGR (Fig.   4D ), which encodes a G protein-coupled receptor that is also mutated in retinitis pigmentosa 52 . We used HOMER 53 to identify transcription factor binding motifs enriched around metabolic-specific eQTL (see
Supplementary Methods).
Two motifs, TEAD1 (p < 1x10 -6 ) and ZEB1 (p < 1x10 -5 ), are amongst the top five motifs in the galactose condition (Table S12 ). TEAD1 is known to play a role in aerobic glycolysis reprogramming 54 , and ZEB1 is known to render cells resistant to glucose deprivation 55 . We did not find enriched motifs in the glucose condition for transcription factors with well-known metabolic functions.
To ascertain whether any genetic regulatory effect is specific to the RPE, we compared fRPE to GTEx eQTL using a previously established two-step FDR approach 56 . We used fRPE shared eQTL (FDR < 0.05 in both metabolic conditions) as the discovery set to remove any treatment-dependent regulatory effect, and used
GTEx eQTL with a relaxed threshold (FDR < 0.1) as the replication set. eQTL from the discovery set not recapitulated in the replicated set were defined as fRPE-selective eQTL. This approach returned three genes ( Fig. 4E-G We found 210 and 193 sQTL at FDR < 0.05 for glucose and galactose conditions, respectively ( Table 2, S13 and S14). The top sQTL in the glucose condition regulates splicing in ALDH3A2 (FDR < 2.06x10 -9 ), which codes for an aldehyde dehydrogenase isozyme involved in lipid metabolism 60 . Mutations in this gene cause Sjogren-Larsson syndrome 61 , which can affect the macular RPE 62 . The top sQTL in the galactose condition regulates splicing of transcripts encoding CAST, a calcium-dependent protease inhibitor involved in the turnover of amyloid precursor protein 63 .
Fine mapping of complex ocular disease risk loci
To assess whether specific instances of GWAS signals can be explained by eQTL or sQTL signals, we performed colocalization analysis with a modified version of eCAVIAR 64 (see Methods). All variants within a 500-kilobase window around any GWAS (p-value < 1x10 -4 ) or QTL (p-value < 1x10 -5 ) signal were used as input to eCAVIAR, and any locus with colocalization posterior probability (CLPP) > 0.01 was considered significant.
Among four genes exceeding this threshold for eQTL and AMD, RDH5, encoding a retinol dehydrogenase that catalyzes the conversion of 11-cis retinol to 11-cis retinal in the visual cycle 65 , showed the most significant colocalization (Fig. 5A , Table S8 ). RHD5 was previously suggested as an AMD candidate gene 42 , but no mechanism was proposed. Two tightly linked AMD-associated variants (rs3138141 and rs3138142, r 2 =0.98) influence RDH5 expression ( exhibit an average of more than three times the amount of exon 3 skipping compared to CC homozygous 8 samples ( Fig. 5H and S22 ). The same e/sQTL also colocalized with a myopia GWAS signal ( Fig. 5D -F, Table   S9 ), suggesting a mechanism for the prior association of the RDH5 locus with myopia 66 and refractive error 13 .
eQTL at PARP12 and CLU also showed evidence of colocalization with AMD and myopia signals, respectively
, but neither locus reached genome-wide significance in the respective GWAS.
Nonsense-mediated decay as a putative mechanism underlying an RDH5 eQTL
The association of the rs3138141/2 minor haplotype with both an RDH5 eQTL and sQTL suggests a mechanistic relationship. The increased skipping of exon 3 (out of 5) associated with the minor haplotype results in more transcripts with a frameshift and a premature termination codon (PTC) near the 5' end of exon 4. Many mammalian transcripts with PTCs are subject to nonsense-mediated decay (NMD), particularly when the PTC is not located in the last exon 67 . Treatment of cells with protein synthesis inhibitors such as cycloheximide (CHX) has been shown to increase the abundance of transcripts subject to NMD 68 . To assess a possible role for NMD in the stability of RDH5 transcripts, we treated differentiated immortalized human RPE cells (ARPE-19) with CHX and quantified the abundance of the normal and skipped exon 3 isoforms by RT-PCR. CHX caused a significant increase in the abundance of the skipped exon 3 isoform as compared to the normal ( Fig. 5I -K). These data are consistent with a model in which the minor haplotype promotes the formation of an aberrant RDH5 mRNA that is subject to NMD, leading to an overall reduction in the steady state levels of RDH5 transcripts.
Discussion
The importance of the RPE for development and lifelong homeostasis of the eye has motivated numerous studies of the RPE transcriptome. Several of these studies proposed similar sets of RPE 'signature' genes, the largest of which comprises 171 genes [29] [30] [31] . Only 23 of these genes are present among our group of 100 fRPEselective protein-coding genes. Our approach of comparing fRPE expression levels to GTEx data, which almost exclusively derive from adult autopsy tissue specimens, may have captured genes highly expressed in cultured and/or fetal cells. Absence in GTEx of pure populations of specialized cell types, especially ocular, may explain other genes in our set. Still, many of the genes we identified are known to serve vital functions in the RPE, as demonstrated by pathway enrichment for pigment synthesis and visual processes. We also 9 identified 30 enriched lncRNAs, a class of transcripts not included in previous signature gene sets. The most highly expressed lncRNA in our list, RMRP, is critical for proper mitochondrial DNA replication and OXPHOS complex assembly in HeLa cells 69 , but its role in the RPE has not yet been investigated. RPE-enriched genes whose functions have not been studied in the tissue afford opportunities for advancing understanding of this important epithelial layer.
Our findings have potential implications for phenotypic variability in monogenic ocular diseases. Mutations in all three of the eQTL so far restricted to the fRPE cause monogenic eye diseases. For example, heterozygous mutations in the transcription factor CRX cause dominant forms of photoreceptor degeneration, which can exhibit variable age at onset and disease progression among members of the same family 4 .
Genetically encoded variation in the transcript levels of normal or mutant CRX alleles may contribute to such variable expressivity. Indeed, mouse models of CRX-associated retinopathies provide evidence for a threshold effect in which small changes in expression cause large differences in phenotype 70 . Mutations in MRFP cause extreme hyperopia (farsightedness). Affected individuals usually have two mutant alleles, but inheritance of a lower-expressing normal allele could explain an affected heterozygous individual in a family with otherwise recessive disease 5 . The substantial number of fRPE eQTL associated with other ocular diseases (Fig. 3A) supports a contribution of common genetic variants to the widespread phenotypic variability observed in monogenic eye disorders.
Our findings also have implications for complex ocular diseases. Evidence suggests that defects in RPE energy metabolism contribute to the pathogenesis of AMD, the hallmark of which is accumulation of cholesterol rich deposits in and around the RPE 71, 72 . Forcing fRPE cells to rely on oxidation of glutamine, the most abundant free amino acid in blood, caused upregulation of genes involved in the synthesis of cholesterol, monounsaturated and polyunsaturated fatty acids, as well as genes associated with lipid import. Transcripts for three of the upregulated genes (FADS1, FADS2, and ACAT2) are increased in macular but not extramacular RPE from individuals with early-stage AMD 73 .
Co-localization of the same RDH5 e/sQTL with both AMD and myopia GWAS loci suggests risk mechanisms for these very different complex diseases. The rs3138141/2 minor haplotype confers an elevated risk for AMD 42 , but is protective for myopia 13, 43, 66 . Reduction in RDH5 activity as a risk factor for AMD is consistent with rare RDH5 loss-of-function mutations that cause recessive fundus albipunctatus, which can 10 include macular atrophy 74, 75 . More puzzling is the relationship between lower RDH5 transcript levels (and presumably enzyme activity) and a reduced risk of myopia. RDH5 is best known for its role in the regeneration of 11-cis retinal in the visual cycle, but the enzyme has also been reported to be capable of producing retinoids suitable for retinoic acid signaling 76, 77 . Evidence from animal models implicates retinoic acid in eye growth regulation
Methods

Sample acquisition and cell culture
Primary human fetal RPE (fRPE) lines were isolated by collecting and freezing non-adherent cells cultured in low calcium medium as described 22 . When needed, fRPE cells were thawed and plated onto 6-well plates in medium as described 23 Genotype data and quality control
All fRPE samples were genotyped on Illumina Infinium Omni2.5-8 BeadChip using the Infinium LCG Assay workflow (https://www.illumina.com/products/by-type/microarray-kits/infinium-omni25-8.html). Samples amplified from 200 ng of genomic DNA were fragmented and hybridized overnight on the Omni2.5-8 BeadChip.
The loaded BeadChips went through single-base extension and staining, and were imaged on the iScan machine to obtain genotype information. We used Beagle v4.1 24 to perform genotype imputation and phasing with 1000 Genomes Project Phase 3 reference panel. Prior to imputation and phasing, we filtered the original VCF file to only bi-allelic SNP sites on autosomes and removed sites with more than 5% missing genotypes.
Beagle was run with default parameters. After imputation and phasing, we removed variants with allelic r 2 < 0.8
and removed multi-allelic variants (variants with more than two alleles). Additional quality control 12 considerations are described in Supplementary Methods. We compared genotypes between every pair of samples and found a pair of duplicated samples (Fig. S5 ) and removed one sample arbitrarily.
Transcriptomic data and quality control RNA was extracted using TRIzol Reagent (Invitrogen) per manufacturer instructions. RNA sequencing was performed on all samples with an RNA integrity number (RIN) of 8.0 or higher and with at least 500 ng total RNA (Table S4) . Stranded, poly-A+ selected RNA-seq libraries were generated using the Illumina TruSeq Stranded mRNA protocol. We performed 75-base paired-end sequencing using an Illumina NextSeq 500.
Glucose and galactose samples from each line were sequenced together to minimize batch effects. Raw data was de-multiplexed using bcl2fastq2 from Illumina with default parameters. Reads were aligned against the hg19 human reference genome with STAR (v2.4.2a) 79 using GENCODE v19 annotations 80 and otherwise default parameters. After alignment, duplicate reads were marked using Picard MarkDuplicates (v2.0.1). We used HTSeq v0.6.0 81 to count the number of reads overlapping each gene based on the GENCODE v19
annotation. We counted reads on the reverse strand (ideal for Illumina's TruSeq library), required a minimum alignment quality of 10, but otherwise used default parameters. We also quantified RPKM using RNA-SeQC v1.1.8 82 using hg19 reference genome and GENCODE v19 annotation with flags "-noDoC -strictMode" but otherwise default parameters. We quantified allele-specific expression using the createASVCF.sh script from RASQUAL 45 with default parameters. For splicing quantification, we used LeafCutter 58 to determine intron excision levels with default parameters. We checked the number of uniquely mapped reads to ensure sufficient number of mapped reads. The RNA-seq libraries have a median number of 46.8 million (88.8%) uniquely mapped reads, with an interquartile range of 41.0 to 55.2 million reads (Fig. S6B) . We ran VerifyBamID 83 with parameters "--ignoreRG --best" on RNA-seq BAM files using genotype VCF files as reference and did not find any sample swaps.
External datasets
We used GTEx V7 18 as a reference dataset to perform RPE-selective gene and RPE-specific eQTL analyses (see Supplementary Methods). The GTEx V7 dataset collected 53 tissues across 714 donors. All tissues across all donors were used in RPE-selective gene analysis. Among the 53 tissues, 48 tissues have sufficient 13 sample size to perform eQTL analysis and were used for RPE-specific eQTL calling. We used two wellpowered ocular disorder GWAS datasets to perform colocalization analysis (Table S1 ). The age-related macular degeneration study 42 is a meta-analysis across 26 studies and identified 52 independent GWAS signals, including 16 novel loci. The myopia GWAS was part of a 42-trait GWAS collection aimed at finding shared genetic influences across different traits 43 . We used ocular disease genes from the Genetic Eye Disease (GEDi) test panel 41 (Table S2) .
RPE-selective gene and pathway enrichment analysis
To identify RPE-selective genes (high expression in RPE relative to other tissues), we inferred expression specificity using the following procedure.
1. Calculate the median expression level (x) across all individuals for each tissue.
2. Calculate the mean (μ) and standard deviation (σ) of median expression values across tissues.
3. Derive a z-score for each tissue as follows: z = (x−μ)/σ.
Define a gene to be tissue-selective if its z-score is greater than 4.
We filtered out genes on sex and mitochondrial chromosomes, and further filtered out genes in HLA region due to low mappability. To determine whether technical confounders (such as batch effect) affected RPE z-scores, we used a QQ-plot to visualize the z-score of each tissue against the average z-score across tissues. Fig. S9 shows that RPE z-scores situate within the midst of z-scores from GTEx tissues. In fact, the only outlier is testis, which is a known outlier from previous studies. We performed GSEA 32 using z-scores as input against GO gene sets from the Molecular Signature Database 84 with 10,000 permutations and otherwise default parameters.
Differential expression and pathway enrichment analysis
We performed differential expression analysis to detect genes whose expression levels were affected by metabolic perturbation. We used DESeq2 34 and corrected for sex, ancestry, RIN, and batch. A simplified mathematical representation is:
We performed pathway enrichment analysis with GSEA using a ranked gene list with 10,000 permutations but otherwise default parameters. The ranking metric was calculated by multiplying the -log 10 (FDR) by the sign of the effect size from DESeq2. For the pathway database, we used a subset of the Molecular Signatures
Database composed of its Hallmark, Biocarta, Reactome, KEGG and GO gene sets 84 .
fRPE-selective genes in ocular diseases
We stratified all protein-coding genes into two groups: 1) ocular disease genes (from GEDi, see section
External datasets) and 2) non-ocular disease genes. To determine whether known ocular disease genes have elevated expression in fRPE, we compared the expression specificity z-score distribution (defined previously) across these two groups with a two-sided t-test. We performed the same analysis for all GTEx tissues as a benchmark. As a control, we repeated this analysis using known epilepsy genes (n = 189) curated from the Invitae epilepsy gene test panel (https://www.invitae.com/en/physician/tests/03401/). GWAS risk loci are frequently enriched around causal genes, which have elevated expression in relevant tissues 85 . To determine whether variants around RPE-selective genes explain higher disease heritability than expected by chance, we performed stratified LD score regression on tissue-selective genes using a previously established pipeline 44 .
Since LD score regression operates on a variant level, we assigned variants within 1-kb around any exon of tissue-selective genes to each tissue. Although many variants show long-range interaction, we restricted our analysis to a conservative window size to capture only nearby cis-effects. We performed LD score regression on the 200, 500, and 1000 tissue-specific genes ( Fig. 3 and Fig. S17 ).
Expression QTL mapping and quality control
We extracted hidden factors from RNA sequencing data using surrogate variable analysis (sva) 86 separately for glucose and galactose samples. Prior to extracting hidden factors, the raw count gene expression data was library size corrected, variance stabilized, and log2-transformed using the R package DESeq2 34 . We ran sva with default parameters and obtained four and five significant surrogate variables for the glucose and galactose conditions, respectively. We performed covariate selection by empirically maximizing the power to detect eQTL.
We randomly selected 50 genes from chromosome 22 to perform covariate selection for computational feasibility (RASQUAL 45 uses a computationally-intensive iterative fitting procedure) and to avoid overfitting.
We added sex, genotype principal components (maximum of three), and surrogate variables sequentially. After multiple hypothesis correction, the number of eAssociations (defined as a SNP-gene pair that passed hierarchical multiple hypothesis testing by TreeQTL 46 ) increased monotonically as the number of covariates, consistent with our intuition that sva only returns significant and independent surrogate variables. Therefore, we decided to use sex, the top three genotype principal components and all surrogate variables (four and five for glucose and galactose conditions, respectively). We mapped eQTL using RASQUAL 45 by jointly modeling gene-level and allele-specific read counts. A simplified mathematical representation is as follows:
Where n = 4 and 5 for glucose and galactose conditions, respectively. We obtained gene-level and association-level FDR using a hierarchical hypothesis correction procedure implemented in TreeQTL 46 using FDR < 0.05 on both gene and association levels. We determined whether the p-values were inflated (e.g. due to model mis-specification) by visualizing their distribution. The distribution suggests that the p-values are slightly conservative (Fig. S10A) . As expected, eQTL with low p-values were enriched around transcription start sites (Fig. S10C ).
We performed multi-tissue eQTL calling using TreeQTL in multi-tissue calling mode. We set the gene as the first level, the treatment as the second level, and the gene-treatment-SNP as the third level and used the FDR < 0.05 for all three levels. To detect RPE-selective genetic regulatory effects, we compared RPE and GTEx eQTL with a two-step FDR approach as described previously 56 . In brief, eQTL shared across both conditions in fRPE were selected (FDR<5%). We decided to filter for shared eQTL as they likely reflect regulatory effect not due to treatments. For each eQTL gene, we screened all GTEx tissues for association at a relaxed FDR < 0.1 and defined an eQTL as RPE-selective if no significant association were found in GTEx.
Splicing QTL calling and quality control
We extracted hidden factors from intron quantification using surrogate variable analysis (sva) 86 separately for glucose and galactose samples with default parameters and obtained two significant surrogate variables each for the glucose and galactose conditions. We performed covariate selection by empirically maximizing the power to detect sQTL using intron clusters from chromosome 1 to avoid overfitting. The number of significant sQTL decreased as the number of covariates increased (Fig. S14) . This is likely because LeafCutter uses the ratio of read counts between each intron and its intron cluster as the molecular phenotype. Intuitively, if a given batch effect influences the read count of an intron, it will likely influence the quantification of other adjacent introns in the same cluster in the same fashion. Taking the ratio between an intron and its intron cluster effectively cancels out such batch effects.
We mapped sQTL separately for two conditions using FastQTL 59 in both nominal and permutation modes and used a simple linear regression:
To obtain cluster-level p-values, we used a conservative approach to correct for family-wise error rate with the Bonferroni procedure across introns within each cluster. Global FDR estimates were calculated using the lowest Bonferroni adjusted p-values per cluster. We used FDR < 0.05 as a significance cutoff. As a quality control, we determined whether the p-values were inflated by visualizing their distribution. The p-values showed a uniform distribution with a spike near 0 (Fig. S15A) . Further, sQTL with low p-values were enriched around splicing donor and acceptor sites (Fig. S15C) , and intronic sQTL SNPs were enriched at intron boundaries (Fig. S15D ).
Fine-mapping of polygenic ocular disease risk loci
We used fRPE eQTL and sQTL information to identify potential causal genes in two well-powered GWAS on age-related macular degeneration and myopia using a modified version of eCAVIAR 64 . For every significant eQTL, we tested all variants within 500-kb of the lead eQTL SNP for colocalization with GWAS summary statistics. At each candidate locus, we ran FINEMAP 87 twice to compute the posterior probability that each individual SNP at the locus was a causal SNP for the GWAS phenotype and fRPE e/sQTL. We then processed the FINEMAP results to compute a colocalization posterior probability (CLPP) using the method described by eCAVIAR 64 . We defined any locus with CLPP > 0.01 to have sufficient evidence for colocalization. At loci that showed colocalization between RPE eQTL and GWAS associations, we performed the colocalization tests again using eQTL from each of 44 GTEx tissues. To determine whether any potential causal genes act primarily through fRPE, we repeated colocalization analysis with GTEx eQTL.
Experimental validation ARPE-19 cells were differentiated for 3 months in 6-well plates (Corning) in medium containing 3 mM pyruvate 88 and treated with 100 µg/mL cycloheximide (CHX; Sigma) or vehicle (DMSO) for 3 hr. Cells were then collected, RNA was extracted by TRIzol (Invitrogen), and cDNA was synthesized with an iScript™ cDNA Synthesis Kit (Bio-RAD). Oligonucleotide primers were designed to specifically amplify the normal or misspliced isoforms of the RDH5 transcript. For the normal isoform, the forward primer (ggggctactgtgtctccaaa) was located in exon 3 and the reverse primer (tgcagggttttctccagact) was located in exon 4, with an expected product size of 151 bp. The amplification conditions were: 94°C 2 min followed by 38 
Code Availability
Code to reproduce all analyses in this manuscript has been deposited on GitHub:
https://github.com/boxiangliu/rpe 
